Featured Research

from universities, journals, and other organizations

Experimental Topical Microbicide Offers Convenient, Long-lasting Protection Against Genital Herpes, Study Suggests

Date:
January 22, 2009
Source:
Albert Einstein College of Medicine
Summary:
A topical microbicide that silences two genes can safely protect against genital herpes infection for as long as one week, according to a new study.

A topical microbicide that silences two genes can safely protect against genital herpes infection for as long as one week, according to a joint study by researchers at the Albert Einstein College of Medicine of Yeshiva University and Harvard Medical School.

Related Articles


Deborah Palliser, Ph.D.The study, carried out in mice and published in Cell Host & Microbe, represents a major step toward developing a vaginal microbicide that offers women convenient, long-lasting protection against herpes infection. Such a microbicide might also help in controlling the AIDS epidemic, since the blisters caused by genital herpes make people more susceptible to HIV infection. The study's principal investigators were Deborah Palliser, Ph.D., assistant professor of microbiology & immunology at Einstein and Judy Lieberman, M.D., Ph.D., professor of pediatrics, Harvard Medical School.

An estimated one in five American adults is infected with herpes simplex virus 2 (HSV-2), which causes the sexually transmitted disease known as genital herpes. Most people don't realize they're infected, since symptoms are often mild and can be mistaken for other conditions. When symptoms do occur, they usually appear as blisters on or around the genitals or rectum. When the blisters break, they leave tender sores that usually take two to four weeks to heal. HSV-2 infection is incurable and persists in the body indefinitely, although the number of outbreaks tends to decrease over time.

The most effective way to prevent the transmission of HSV-2 is to avoid sexual contact during an active outbreak and to use condoms for sexual contact between outbreaks. When an outbreak occurs, promptly taking the suppressive antiviral drug valacyclovir can help minimize symptoms and reduce the risk of transmitting the virus.

The microbicide in this study is based on RNA interference (RNAi), a mechanism cells use to protect their genetic machinery from viruses and other threats. RNAi employs short, double-stranded RNAs called small interfering RNAs, or siRNAs. In 2001, scientists discovered that synthetic siRNAs can induce RNA interference in mammalian cells — a finding that has triggered interest in harnessing this strategy for biomedical research and drug development.

The HSV-2 microbicide used in this study inactivates two genes via RNA interference. One siRNA targets a viral gene, thereby silencing virus immediately following application, but suppression lasts for only a couple of days. The second siRNA — specific for a cell-surface protein used by HSV-2 to dock onto cells it infects — takes a few days to silence the gene, but then confers suppression for a week.

By combining the fast-acting-but-short-lived RNAi with the slower-acting-but-long-lived RNAi, the researchers created a vaginal microbicide offering protection that was both immediate (even warding off an HSV-2 "challenge" given shortly before the microbicide was applied) and sustained (protecting against HSV-2 challenge for a week after application).

"A good microbicide for a sexually transmitted disease must offer long-term protection — compliance will be problematic if it has to be applied immediately before sexual intercourse," says Dr. Palliser. "Our microbicide, with its two siRNAs, provided sustained and uninterrupted protection against HSV-2 infection. And equally important, we achieved these results without causing inflammation of vaginal tissue — a side effect observed with other siRNAs that also risks neutralizing a microbicide's benefits. We're hopeful that this experimental microbicide can be turned into a cost-effective therapy for use in developing countries where up to 80 percent of the population is infected with HSV-2." The researchers are currently working to refine the microbicide and as yet have no plans for clinical trials.

In addition to Dr. Lieberman, Dr. Palliser's coauthors are lead author Yichao Wu, and Francisco Navarro, Ashish Lal, and Emre Basar, of Harvard Medical School, Cambridge, Mass; Rajendra K. Pandey and Muthiah Manoharan of Alnylam Pharmaceuticals, Cambridge, Mass.; and Yang Feng and Sandra J. Lee of the Dana Farber Cancer Institute, Boston, Mass.


Story Source:

The above story is based on materials provided by Albert Einstein College of Medicine. Note: Materials may be edited for content and length.


Cite This Page:

Albert Einstein College of Medicine. "Experimental Topical Microbicide Offers Convenient, Long-lasting Protection Against Genital Herpes, Study Suggests." ScienceDaily. ScienceDaily, 22 January 2009. <www.sciencedaily.com/releases/2009/01/090121122840.htm>.
Albert Einstein College of Medicine. (2009, January 22). Experimental Topical Microbicide Offers Convenient, Long-lasting Protection Against Genital Herpes, Study Suggests. ScienceDaily. Retrieved December 17, 2014 from www.sciencedaily.com/releases/2009/01/090121122840.htm
Albert Einstein College of Medicine. "Experimental Topical Microbicide Offers Convenient, Long-lasting Protection Against Genital Herpes, Study Suggests." ScienceDaily. www.sciencedaily.com/releases/2009/01/090121122840.htm (accessed December 17, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Wednesday, December 17, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

UN: Up to One Million Facing Hunger in Ebola-Hit Countries

UN: Up to One Million Facing Hunger in Ebola-Hit Countries

AFP (Dec. 17, 2014) Border closures, quarantines and crop losses in West African nations battling the Ebola virus could lead to as many as one million people going hungry, UN food agencies said on Wednesday. Duration: 00:52 Video provided by AFP
Powered by NewsLook.com
When You Lose Weight, This Is Where The Fat Goes

When You Lose Weight, This Is Where The Fat Goes

Newsy (Dec. 17, 2014) Can fat disappear into thin air? New research finds that during weight loss, over 80 percent of a person's fat molecules escape through the lungs. Video provided by Newsy
Powered by NewsLook.com
Flu Outbreak Closing Schools in Ohio

Flu Outbreak Closing Schools in Ohio

AP (Dec. 17, 2014) A wave of flu illnesses has forced some Ohio schools to shut down over the past week. State officials confirmed one pediatric flu-related death, a 15-year-old girl in southern Ohio. (Dec. 17) Video provided by AP
Powered by NewsLook.com
Yoga Could Be As Beneficial For The Heart As Walking, Biking

Yoga Could Be As Beneficial For The Heart As Walking, Biking

Newsy (Dec. 17, 2014) Yoga can help your weight, blood pressure, cholesterol and heart just as much as biking and walking does, a new study suggests. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins